- Home
- Clinical Trials
Atopic Dermatitis Studies Kapiti
Atopic Dermatitis Studies
Kapiti
Do you struggle with moderate to severe atopic dermatitis (eczema)?
Momentum Clinical Research is conducting a clinical research study investigating a potential new medication for eczema designed to help relieve itching, reduce inflammation and improve overall skin health.
By taking part, you may receive a potential new medication option for AD, receive regular health checks, and contribute to medical research that could benefit people in the future.
Description
What to expect
Study details
Ages
18 to 65 years of age
Duration
Up to 13 months with around 14 clinic visits, 3 of which are dosing visits
Compensation
Participants will be compensated up to $6490
Eligibility Criteria
You may qualify for this study if you:
- Are 18 to 65 years of age
- Have moderate-to-severe eczema (covering about 10 palm sized handprints over your body)
- Have had eczema (atopic dermatitis) for at least 1 year
Other criteria may apply.
Locations
Description
Atopic dermatitis, also known as eczema, is a chronic skin condition that can make your skin feel dry, itchy, and sore. It can come and go, showing up as red, irritated patches that may make daily life uncomfortable and have an impact on sleep, physical comfort and self-confidence.
Flare ups of symptoms can be caused by a wide range of triggers including changes in temperature, allergens in the environment or food, stress, certain clothing or fabrics and hormonal changes. With eczema, your skin’s protective layer is a bit weaker, which makes it more susceptible to irritants.
Current treatments include topical creams and corticosteroids, but these options don’t always provide lasting relief creating a need for a more effective medication.
This study is exploring whether a new investigational medication could help people living with moderate-to-severe atopic dermatitis (eczema) by blocking the immune signals involved in itch and inflammation associated with atopic dermatitis.
The study compares the investigational medication with a placebo to better understand its safety and effects.
What to expect
Participants will be randomly assigned to receive either the investigational medication or a placebo (inactive substance) through three IV infusions over the span of 4 weeks.
You will visit the clinic regularly for health assessments, including skin evaluations, physical examinations, and general checkups. Your safety and well-being will be closely monitored by a professional clinical team.
Why join this clinical research study?
- Receive a new potential medication for AD at no cost
- Be part of medical research aiming to improve treatment options for eczema
- Learn to better manage your condition
- Receive health checks and advice from our professional medical team
Your privacy is important and all personal information will be kept strictly confidential.
Register your interest today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.